For now, however, curiosity should be balanced with caution
of note, the clinical relevance of IFN--induced suppression of JAK2 V617F allele burden, which is seen in a small minority of patients 47 , and also documented with busulfan therapy 51 , is unclear
As these therapies evolve, primary care will be at the forefront of integrating them into holistic, patient-centered management, says Kyle Lee, BMLSc, BMBS, MPH, CCFP, Sermo medical advisory board member, in a release
Magnesium glycinate is typically considered to be safe to use alongside GLP-1 medications such as semaglutide or tirzepatide. Our expert says GLP-1 users have been consistently identified as at risk of micronutrient deficiencies, including magnesium deficiency, so it is paramount to discuss this possibility with the physician who prescribed the meds